Back to search

Boston University

Targeting beta-catenin coactivator signaling impedes tumor growth and reprograms the tumor microenvironment in head and neck cancer

Abstract

dc:description.abstract

Cyclic AMP responsive element binding protein binding protein (CBP) is a transcriptional coactivator that partners with β-catenin to promote gene expression programs associated with tumor evolution. We hypothesized that pharmacologic disruption of this complex would suppress tumor progression in head and neck cancer through coordinated effects on epithelial tumor cells and the tumor immune microenvironment. Here, we demonstrate that pharmacologic disruption of the β-catenin–CBP interaction with the small molecule inhibitor E7386 suppresses tumor growth and remodels the tumor immune microenvironment. In cultured tumor cells, E7386 reduces CBP abundance and shifts transcription from proliferation toward apoptotic cell death. Using the 4MOSC1 carcinogen-induced orthotopic isograft mouse model, E7386 treatment significantly reduces tumor volume and increases cleaved caspase 3 expression. Single-cell RNA sequencing also reveals depletion of differentiated epithelial cells, reduction of intratumoral regulatory T cells, and selective expansion of lipid-associated macrophages (LAMs). Cell–cell signaling and immunofluorescence analyses identify bidirectional epithelial–myeloid interactions associated with increased macrophage presence at sites of epithelial cell death. Upon withdrawal of E7386 treatment, we observe a transient LAM response, suggesting that macrophage infiltration may serve as an indicator of durable treatment response. Collectively, our data show that disruption of the β-catenin–CBP complex suppresses tumor progression by inducing cancer cell death and promoting macrophage-mediated phagocytosis.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pharmacology
Grantor
Boston University
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fisher, Emily R.
Advisor dc:contributor.advisor
  • Kukuruzinska, Maria A
ORCID dc:identifier.orcid

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/53462

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Fisher, Emily R.. Targeting beta-catenin coactivator signaling impedes tumor growth and reprograms the tumor microenvironment in head and neck cancer. doctoral thesis, Boston University, 2026. https://hdl.handle.net/2144/53462